David Hoey
Director/Board Member at UNIVERSAL BIOSENSORS, INC.
Net worth: 64 517 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Salesh Balak | M | 54 |
Universal Biosensors Pty Ltd.
Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia. | 18 years |
Andrew Leslie Denver | M | 75 |
Vaxxas, Inc.
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | 22 years |
Graham Mclean | M | 59 | 2 years | |
Marshall Heinberg | M | 67 |
Universal Biosensors Pty Ltd.
Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia. | 12 years |
John Sharman | M | 57 |
Universal Biosensors Pty Ltd.
Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia. | 4 years |
Judith Smith | F | 68 |
Universal Biosensors Pty Ltd.
Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia. | 9 years |
Craig Coleman | M | 58 |
Universal Biosensors Pty Ltd.
Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia. | 8 years |
Ann Chew | F | - | 16 years | |
Stephen Thompson | M | - |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | - |
Mark Richard Ashton | M | 56 |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | - |
Dean Moss | M | - |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | - |
Paul James Kelly | M | - |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | 13 years |
Angus Forster | M | - |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | - |
Doug Onsi | M | 55 |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | 13 years |
Luke Cossins | M | - | 12 years | |
Nicholas Bliesner | M | - | - | |
Julian Hickling | M | - |
Vaxxas Pty Ltd.
Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | - |
Steven Burgess | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Paul Wright | M | 59 |
Universal Biosensors Pty Ltd.
Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia. | 5 years |
Adrian Oates | M | 62 |
Universal Biosensors Pty Ltd.
Universal Biosensors Pty Ltd. Medical SpecialtiesHealth Technology Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia. | 12 years |
C. Merrifield | F | 73 |
PathoGenetix, Inc.
PathoGenetix, Inc. BiotechnologyHealth Technology PathoGenetix, Inc. operates as a commercial-stage developer of an automated system for rapid bacterial identification from complex samples. Its Genome Sequence Scanning technology isolates and analyzes DNA from an enriched biological sample, without the need for a cultured isolate. The firm specializes in food safety, industrial microbiology, and clinical diagnostics and research. The company was founded in 1997 and is headquartered in Watertown, MA. | 2 years |
Garry Chambers | M | 60 | 16 years | |
Denis Hanley | M | 75 | 16 years | |
John J. Canepa | M | 68 |
PathoGenetix, Inc.
PathoGenetix, Inc. BiotechnologyHealth Technology PathoGenetix, Inc. operates as a commercial-stage developer of an automated system for rapid bacterial identification from complex samples. Its Genome Sequence Scanning technology isolates and analyzes DNA from an enriched biological sample, without the need for a cultured isolate. The firm specializes in food safety, industrial microbiology, and clinical diagnostics and research. The company was founded in 1997 and is headquartered in Watertown, MA. | 9 years |
Jason Lemaire | M | - | 11 years | |
Rick Legleiter | M | 65 | 2 years | |
Cameron Billingsley | M | 47 | 17 years | |
Alastair Hodges | M | 64 | 16 years | |
Steven Goeby | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
Australia | 27 | 93.10% |
United States | 3 | 10.34% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Hoey
- Personal Network